Despite major strides in antiretroviral therapy (ART), the human immunodeficiency virus (HIV) market still faces serious ...

The field of HIV treatment has witnessed a significant transformation since the mid-1990s with the introduction of combination antiretroviral therapy ...

Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV.

However, treatment options remain limited, as only a small percentage of those affected receive the necessary care. Currently, 11 countries (45%) in the Middle East and North Africa offer opioid ...

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

Qonita Anjani, Research Fellow at Queen’s University has been announced as the joint winner of the 2025 ‘Outstanding Pharmacy ...

The parenteral nutrition market is growing rapidly, driven by chronic disease prevalence, aging populations, and innovations ...